Luceome Biotechnologies
Tucson
About Luceome Biotechnologies
Luceome Biotechnologies offers cell-based and in vitro kinase assay services for drug discovery using its hybrid split-luciferase technology. They provide assay solutions that are based on a technology platform that utilises luciferase fragment complementation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.9M
- Last round: Grant (Aug 2011)
- Website: luceome.com
- Phone: 520-495-0161
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/luceome-biotechnologies-2817849 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.